Blood Advances
ISSN: 2473-9529
eISSN: 2476-9537
Publisher: American Society of Hematology
Publications (38)
Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD (2024)
Etra A, Jurdi NE, Katsivelos N, Kwon D, Gergoudis S, Morales G, Spyrou N, et al.
Journal article
Adoptive transfer of donor B lymphocytes: a phase 1/2a study for patients after allogeneic stem cell transplantation. (2024)
Winkler J, Tittlbach H, Schneider A, Vasova I, Strobel J, Herold S, Maas S, et al.
Journal article
Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis. (2024)
Akahoshi Y, Spyrou N, Hoepting M, Aguayo-Hiraldo P, Ayuk F, Chanswangphuwana C, Choe HK, et al.
Journal article
Applying the EHA/EBMT grading for ICAHT after CAR-T: comparative incidence and association with infections and mortality. (2024)
Rejeski K, Wang Y, Hansen DK, Iacoboni G, Bachy E, Bansal R, Penack O, et al.
Journal article
Outcomes of axicabtagene ciloleucel in PMBCL compare favorably with those in DLBCL: a GLA/DRST registry study (2023)
Schubert ML, Bethge WA, Ayuk FA, von Bonin M, Vucinic V, Wagner-Drouet EM, Subklewe M, et al.
Journal article
Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease (2023)
Al Malki MM, London K, Baez J, Akahoshi Y, Hogan WJ, Etra A, Choe H, et al.
Journal article
The utility of biomarkers in acute GVHD prognostication (2023)
Spyrou N, Akahoshi Y, Ayuk F, Holler E, Choe H, Etra A, Hogan WJ, et al.
Journal article
Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD (2023)
Akahoshi Y, Spyrou N, Hogan WJ, Ayuk F, DeFilipp Z, Weber D, Choe HK, et al.
Journal article
Large case-control study indicates no association of KIR genotype and risk of developing acute myeloid leukemia (2023)
Heidenreich F, Falk B, Baldauf H, Massalski C, Schäfer G, Rücker-Braun E, Altmann H, et al.
Journal article
CD19 CAR T cells are an effective therapy for posttransplant relapse in patients with B-lineage ALL: real-world data from Germany (2023)
Bader P, Rossig C, Hutter M, Ayuk FA, Baldus CD, Bücklein VL, Bonig H, et al.
Journal article